TWR 0.63% 78.5¢ tower limited ordinary shares

Ann: ASSET: TWR: TOWER sells health insurance bus

  1. lightbulb Created with Sketch. 2
    • Release Date: 02/11/12 11:58
    • Summary: ASSET: TWR: TOWER sells health insurance business
    • Price Sensitive: No
    • Download Document  3.75KB
    					
    
    TWR
    02/11/2012 09:58
    ASSET
    
    REL: 0958 HRS Tower Limited
    
    ASSET: TWR: TOWER sells health insurance business
    
    2 November 2012
    
    For immediate release
    
    Market Information
    NZX Limited
    Level 2, NZX Centre
    11 Cable Street
    Wellington
    New Zealand
    
    Company Announcements Office
    Australian Stock Exchange Limited
    Exchange Centre
    Level 6, 20 Bridge Street
    Sydney NSW 2000
    AUSTRALIA
    
    TOWER sells health insurance business
    
    (Auckland - NZ) TOWER Limited today announced it has sold its health
    insurance business, TOWER Medical Insurance Limited, to nib holdings limited
    (nib) for approximately NZD$102 million.
    nib is one of Australia's fastest-growing health funds, providing affordable
    health cover to more than 900,000 customers throughout Australia. It is the
    only ASX-listed Australian private health insurer (ASX: nhf).
    TOWER Group Managing Director Rob Flannagan said the sale of TOWER Medical
    Insurance Limited followed a strategic review of the Group's business,
    announced earlier in the year.
    "We have carefully assessed our involvement in and outlook for each of the
    insurance markets in which TOWER operates. We do not consider that we will be
    able to achieve the necessary scale or return in this business in the
    immediate future, and therefore have made the strategic decision to sell
    TOWER Medical Insurance Limited."
    nib's Managing Director, Mark Fitzgibbon, said the acquisition is in line
    with nib's strategy of expanding its operations into international markets.
    "nib has been investigating opportunities in New Zealand for some time. TOWER
    Medical meets nib's strict investment criteria in terms of strategic
    rationale and return on investment," Mr Fitzgibbon said.
    "With a market share of approximately 13%, TOWER Medical provides an
    opportunity to emulate the success nib has achieved in Australia since its
    listing in 2007 through brand building, product design, distribution and
    outstanding customer service," he said.
    "In addition to leveraging our own core capabilities, TOWER Medical has had
    success working with financial advisers and we look forward to working with
    them to further develop this important distribution channel to grow market
    share," Mr Fitzgibbon added.
    Mr Flannagan said TOWER would be working closely with nib to ensure that
    customers continued to receive the high standards of service they had come to
    expect from TOWER Medical Insurance Limited.
    "nib's customer service expertise and strong track record in medical
    insurance will bring obvious benefits to our customers and the broader New
    Zealand market.
    "We look forward to working together with nib and to building a long-term
    relationship that will deliver benefits to TOWER customers through the
    insights, expertise and strong track record in medical insurance that nib
    will bring to the New Zealand market."
    
    Mr Flannagan said the TOWER Board was satisfied with the sale price of
    approximately $102 million that had been achieved. Capital management was a
    key focus for the Board, and it intended repaying capital to shareholders of
    not less than the proceeds of the sale.
    The sale of TOWER Medical Insurance Limited to nib is subject to Overseas
    Investment Office approval and other conditions customary for a transaction
    of this type. Subject to satisfaction and timing of conditions, settlement is
    likely to occur before 31 December 2012.
    TOWER expects its Group net profit after tax for the year ended 30 September
    2012 to exceed the upper end of published analyst ranges. Net profit after
    tax is expected to be in the range of $51 million to $56 million, including a
    positive $9 million discount rate effect.
    
    Ends
    
    For further information, please contact:
    Rob Flannagan
    Group Managing Director
    TOWER Limited
    Tel:  +64 9 369 2279
    ARBN 088 481 234 Incorporated in New Zealand
    End CA:00229257 For:TWR    Type:ASSET      Time:2012-11-02 09:58:21
    				
 
watchlist Created with Sketch. Add TWR (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.